يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Denis I. Zrelkin"', وقت الاستعلام: 1.20s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

    المؤلفون: Amir I. Tukhvatulin, Inna V. Dolzhikova, Alina S. Dzharullaeva, Daria M. Grousova, Anna V. Kovyrshina, Olga V. Zubkova, Ilya D. Zorkov, Anna A. Iliukhina, Artem Y. Shelkov, Alina S. Erokhova, Olga Popova, Tatiana A. Ozharovskaia, Denis I. Zrelkin, Fatima M. Izhaeva, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Elisaveta A. Tokarskaya, Natalia A. Nikitenko, Nadezhda L. Lubenets, Elizaveta A. Khadorich, Vladimir A. Gushchin, Svetlana N. Borzakova, Anna V. Vlasova, Ismail M. Osmanov, Valerii V. Gorev, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg

    المصدر: Frontiers in Immunology, Vol 14 (2023)

    مصطلحات موضوعية: Sputnik M, Sputnik V, Gam-COVID-Vac, SARS-CoV-2, COVID-19, Immunologic diseases. Allergy, RC581-607

    وصف الملف: electronic resource

    Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1228461/full; https://doaj.org/toc/1664-3224

    URL الوصول: https://doaj.org/article/eccefe49c05d44c496a720e9225bf865

    Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus

    المؤلفون: Vladimir A. Gushchin, Darya A. Ogarkova, Inna V. Dolzhikova, Olga V. Zubkova, Igor V. Grigoriev, Andrei A. Pochtovyi, Anna A. Iliukhina, Tatiana A. Ozharovskaia, Nadezhda A. Kuznetsova, Daria D. Kustova, Artem Y. Shelkov, Denis I. Zrelkin, Alina S. Odintsova, Daria M. Grousova, Vladislav Y. Kan, Sona A. Davtyan, Andrei E. Siniavin, Elizaveta D. Belyaeva, Andrei G. Botikov, Arina A. Bessonova, Lyudmila A. Vasilchenko, Daria V. Vasina, Denis A. Kleymenov, Egor A. Slutskiy, Artem P. Tkachuk, Olga A. Burgasova, Svetlana Y. Loginova, Evgeny V. Rozhdestvensky, Dmitry V. Shcheblyakov, Alexander N. Tsibin, Andrey G. Komarov, Vladimir I. Zlobin, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg

    المصدر: Frontiers in Immunology, Vol 13 (2022)

    مصطلحات موضوعية: monkeypox virus (MPXV), orthopoxvirus, vaccinia virus (VACV), immunity, neutralizing antibody titers (NAT), Immunologic diseases. Allergy, RC581-607

    وصف الملف: electronic resource

    Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2022.1023164/full; https://doaj.org/toc/1664-3224

    URL الوصول: https://doaj.org/article/84ad75d454a44bc8b7f615c5d10c8ed5

    Full Text Finder
    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine 'Sputnik Light' for prevention of coronavirus infection in healthy adults

    المؤلفون: Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg

    المصدر: The Lancet Regional Health. Europe, Vol 11, Iss , Pp 100241- (2021)

    مصطلحات موضوعية: Public aspects of medicine, RA1-1270

    وصف الملف: electronic resource

    Relation: http://www.sciencedirect.com/science/article/pii/S2666776221002271; https://doaj.org/toc/2666-7762

    URL الوصول: https://doaj.org/article/54fc97d8b69745aa9da8b8b6bf909e3d

    Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  4. 4
    [Review of candidate vaccines for the prevention of Lassa fever]

    المؤلفون: B.S. Naroditsky, T A Ozharovskaia, Dmitry V. Shcheblyakov, Denis I. Zrelkin, Inna V. Dolzhikova, Olga Popova, Alexander L. Gintsburg, Daria V Voronina, D Yu Logunov, Olga V. Zubkova

    المصدر: Voprosy virusologii. 66(2)

    مصطلحات موضوعية: 0301 basic medicine, viruses, 030106 microbiology, Diagnostic tools, medicine.disease_cause, Sierra leone, 03 medical and health sciences, Lassa Fever, Virology, Medicine, Humans, Lassa fever, Lassa virus, business.industry, Viral Vaccines, General Medicine, medicine.disease, Europe, Hemorrhagic Fevers, West african, Africa, Western, 030104 developmental biology, Infectious Diseases, Recombinant vaccines, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eab7212a28ec008759c557a0bb64d394
    https://pubmed.ncbi.nlm.nih.gov/33993679

    أضف إلى المفضلة
  5. 5
    Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

    المؤلفون: A. I. Tukhvatulin, Fatima M. Izhaeva, Denis Y. Logunov, Daria A. Egorova, Daria M. Grousova, Andrei G. Botikov, Alina S. Dzharullaeva, Sergei V. Borisevich, Olga Popova, Denis I. Zrelkin, Ilias B Esmagambetov, Alexander S. Semikhin, Daria V Voronina, Elena A Smolyarchuk, Dmitry N. Shcherbinin, Olga V. Zubkova, Nadezhda L. Lubenets, M M Shmarov, Anna V. Kovyrshina, Tatiana A Ozharovskaya, Boris S. Naroditsky, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Alexander L. Gintsburg, Irina A Favorskaya, Alina S. Erokhova, Natalia A. Nikitenko, Vladimir A. Gushchin, Sergey Zyryanov, Yana V. Simakova, Elizaveta A. Tokarskaya

    المصدر: The Lancet
    Lancet (London, England)

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, COVID-19 Vaccines, Immunization, Secondary, 030204 cardiovascular system & hematology, Placebo, Antibodies, Viral, Injections, Intramuscular, Moscow, law.invention, Russia, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Internal medicine, medicine, Data monitoring committee, Humans, 030212 general & internal medicine, Case report form, Vaccines, Synthetic, business.industry, SARS-CoV-2, COVID-19, Articles, General Medicine, Middle Aged, Interim analysis, Vaccine efficacy, Clinical trial, Vaccination, Spike Glycoprotein, Coronavirus, Female, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45be4c8958b8b211911b441dc840d66e

    View record from ScienceDirect Find this article in full text from ProQuest Full Text via ClinicalKey
    أضف إلى المفضلة
  6. 6
    An Open, Non-Randomised, 1/2 Phase Study on the Safety, Tolerability, and Immunogenicity of Single Dose 'Sputnik Light' Vaccine for Prevention of Coronavirus Infection in Healthy Adults

    المؤلفون: Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg

    المصدر: SSRN Electronic Journal.

    مصطلحات موضوعية: Vaccination, Clinical trial, medicine.medical_specialty, Cellular immunity, Tolerability, business.industry, Immunity, Internal medicine, Immunogenicity, Medicine, Seroconversion, business, Adverse effect

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::46dd4f7e36c0425bc50de16bb4665594
    https://doi.org/10.2139/ssrn.3886430

    أضف إلى المفضلة
  7. 7
    Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

    المؤلفون: Tatiana A Ozharovskaya, Nadezhda L. Lubenets, Sergei V. Borisevich, Alexander S. Semikhin, Daria M. Grousova, Andrei G. Botikov, Yana V. Simakova, Fatima M. Izhaeva, Alina S. Erokhova, Denis I. Zrelkin, Olga V. Zubkova, Irina A Favorskaya, Elena A Smolyarchuk, Boris S. Naroditsky, M M Shmarov, Natalia A. Nikitenko, Alina S. Dzharullaeva, Alexander L. Gintsburg, Morozova Lf, Daria A. Egorova, Evgeny V Kryukov, Dmitry V. Shcheblyakov, Olga Popova, Denis Y. Logunov, Dmitry N. Shcherbinin, Inna V. Dolzhikova, Amir I Tukhvatullin, Elizaveta A. Tokarskaya, Ilias B Esmagambetov, Vladimir F Babira, Anna V. Kovyrshina, Daria V Voronina

    المصدر: Yana Simakova
    Lancet (London, England)
    The Lancet

    مصطلحات موضوعية: medicine.medical_specialty, Cellular immunity, business.industry, Immunogenicity, Viral Vaccine, Articles, General Medicine, 030204 cardiovascular system & hematology, Vaccination, 03 medical and health sciences, 0302 clinical medicine, Immunity, Internal medicine, Humoral immunity, medicine, 030212 general & internal medicine, Seroconversion, business, Adverse effect

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b04ada67ad427528778d88936c6006e

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء